This isolate belongs to a unique set of HSV-1 isolates cultured from corneal swabs taken from deceased corneas of otherwise healthy immunecompetent patients with a history of recurrent HSV-1 keratitis in The Netherlands.
This isolate belongs to a unique set of HSV-1 isolates cultured from corneal swabs taken from deceased corneas of otherwise healthy immunecompetent patients with a history of recurrent HSV-1 keratitis in The Netherlands.
This isolate belongs to a unique set of HSV-1 isolates cultured from corneal swabs taken from deceased corneas of otherwise healthy immunecompetent patients with a history of recurrent HSV-1 keratitis in The Netherlands.
This isolate belongs to a unique set of HSV-1 isolates cultured from corneal swabs taken from deceased corneas of otherwise healthy immunecompetent patients with a history of recurrent HSV-1 keratitis in The Netherlands.
This clone belongs to a unique set of HIV-2 biological clones from West African immigrants in The Netherlands. Clones were obtained from patients with non-progressive, aviremic or progressive, viremic HIV-2 infection.
Unit: Vial with 1 ml infectious culture supernatant.
This clone belongs to a unique set of HIV-2 biological clones from West African immigrants in The Netherlands. Clones were obtained from patients with non-progressive, aviremic or progressive, viremic HIV-2 infection.
Unit: Vial with 1 ml infectious culture supernatant
This clone belongs to a unique set of HIV-2 biological clones from West African immigrants in The Netherlands. Clones were obtained from patients with non-progressive, aviremic or progressive, viremic HIV-2 infection.
Unit: Vial with 1 ml infectious culture supernatant
This clone belongs to a unique set of HIV-2 biological clones from West African immigrants in The Netherlands. Clones were obtained from patients with non-progressive, aviremic or progressive, viremic HIV-2 infection.
Unit: Vial with 1 ml infectious culture supernatant.
This clone belongs to a unique set of HIV-2 biological clones from West African immigrants in The Netherlands. Clones were obtained from patients with non-progressive, aviremic or progressive, viremic HIV-2 infection.
Unit: Vial with 1 ml infectious culture supernatant.
This clone belongs to a unique set of HIV-2 biological clones from West African immigrants in The Netherlands. Clones were obtained from patients with non-progressive, aviremic or progressive, viremic HIV-2 infection.
Unit: Vial with 1 ml infectious culture supernatant.
This clone belongs to a unique set of HIV-2 biological clones from West African immigrants in The Netherlands. Clones were obtained from patients with non-progressive, aviremic or progressive, viremic HIV-2 infection.
Unit: Vial with 1 ml infectious culture supernatant.
This clone belongs to a unique set of HIV-2 biological clones from West African immigrants in The Netherlands. Clones were obtained from patients with non-progressive, aviremic or progressive, viremic HIV-2 infection.
Unit: Vial with 1 ml infectious culture supernatant
This clone belongs to a unique set of HIV-2 biological clones from West African immigrants in The Netherlands. Clones were obtained from patients with non-progressive, aviremic or progressive, viremic HIV-2 infection.
Unit: Vial with 1 ml infectious culture supernatant.
This clone belongs to a unique set of HIV-2 biological clones from West African immigrants in The Netherlands. Clones were obtained from patients with non-progressive, aviremic or progressive, viremic HIV-2 infection.
Unit: Vial with 1 ml infectious culture supernatant.
This clone belongs to a unique set of HIV-2 biological clones from West African immigrants in The Netherlands. Clones were obtained from patients with non-progressive, aviremic or progressive, viremic HIV-2 infection.
Unit: Vial with 1 ml infectious culture supernatant.
This clone belongs to a unique set of HIV-2 biological clones from West African immigrants in The Netherlands. Clones were obtained from patients with non-progressive, aviremic or progressive, viremic HIV-2 infection.
Unit: Vial with 1 ml infectious culture supernatant.
This rabies virus (145/16) is preserved under viral storage medium at -80C. Test for the presence of mycoplasma were performed. The virus has been partially sequenced
This rabies virus (551/16) is preserved under viral storage medium at -80C. Tests for the presence of mycoplasma were performed. The virus has been partially sequenced.
